abstract |
The present invention relates to the new compound rac-isopropyl- (2-methoxyethyl) -4- (2-chloro-3-cyano-phenyl) -1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate and its pure enantiomers, processes for their production and their use as medicaments, in particular for the treatment of cerebral and neuronal diseases, and a new intermediate for their production. |